Gene transfer to cerebral blood vessels after subarachnoid hemorrhage

Stroke

Volumn 28, Issue 4, 1997, Pages 822-829

  Muhonen, Michael G ^b   Ooboshi, Hiroaki ^b   Welsh, Michael J ^b   Davidson, Beverly L ^b   Heistad, Donald D ^a  

^a UNIVERSITY OF IOWA   (United States)

^b NONE

Author keywords

dogs; gene therapy; subarachnoid hemorrhage; vasospasm

Indexed keywords

BETA GALACTOSIDASE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BRAIN BLOOD VESSEL; BRAIN VASOSPASM; CISTERNA MAGNA; CONTROLLED STUDY; DOG; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; MALE; NONHUMAN; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; TRANSGENE; VERTEBRAL ARTERIOGRAPHY; VIRUS RECOMBINANT;

EID: 0030966110     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.4.822     Document Type: Article

References (36)

1. Kiwak KJ, Heros RC. Cerebral vasospasm after subarachnoid hemorrhage. Trend Neurosci. 1987;10:89-92.
2. MacDonald RL, Weir BKA. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke. 1991;22:971-982.
3. Shinyama H, Uchida T, Kido H, Hayashi K, Watanabe M, Matsumura Y, Ikegawa R, Takaoka M, Morimoto S. Phosphoramidon inhibits the conversion of intracisternally administered big endothelin-1 to endothelin-1. Biochem Biophys Res Commun. 1991; 178:24-30.
4. Egeman N, Turker RK, Sanlidilek U, Zorlutuna A, Blilgic S, Baskaya M, Unlu A, Caglar S, Spetzler RF, McCormick JM. The effect of intrathecal sodium nitroprusside on severe chronic vasospasm. Neurol Res. 1993;15:310-315.
5. Juul R, Aakhus S, Bjornstad K, Gisvold SE, Brubakk AO, Edvinsson L. Calcitonin gene-related peptide (human α-CGRP) counteracts vasoconstriction in human subarachnoid haemorrhage. Neurosci Lett. 1994;170:67-70.
6. Kajita Y, Suzuki Y, Oyama H, Tanazawa T, Takayasu M, Shibuya M, Sugita K. Combined effects of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs. J Neurosurg. 1994;80:476-483.
7. Rosenberg MB, Friedmann T, Robertson RC, Tuszynski M, Wolff JA, Breakefield XO, Gage FH. Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression. Science. 1988;242:1575-1578.
8. Dobson AT, Margolis TP, Sedarati F, Stevens JG, Feldman LT. A latent, nonpathogenetic HSV-1 derived vector stably expresses β-galactosidase in mouse neurons. Neuron. 1990;5:353-360.
9. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM. In vivo gene transfer with retroviral vector-produced cells for treatment of experimental brain tumors. Science. 1992;256: 1550-1552.
10. Lal B, Cahan MA, Couraud P-O, Goldstein GW. Development of endogenous β-galactosidase and aurofluorescence in rat brain microvessels: implication for cell tracking and gene transfer studies. J Histochem Cytochem. 1994;42:953-956.
11. Bajocchi G, Feldman SH, Crystal RG, Mastrangeli A. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nat Genet. 1993;3:229-234.
12. Davidson BL, Allen ED, Kozarsky KF, Wilson JM, Roessler BJ. A model system for in vivo gene transfer into the central nervous system using adenoviral vector. Nat Genet. 1993;3:219-223.
13. Akli S, Caillaud C, Vigne E, Stratford-Perricaudet LD, Poenaru L, Perricaudet M, Kahn A, Peschanski MR. Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet. 1993;3:224-228.
14. Betz AL, Yang G-Y, Davidson BL. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J Cereb Blood Flow Metab. 1995;15:547-551.
15. Heistad DD, Faraci FM. Gene therapy for cerebral vascular disease. Stroke. 1996;27:1688-1693.
16. Yao SN, Wilson JM, Nabel EG, Kurachi S, Hachiya HL, Kurachi K. Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B. Proc Natl Acad Sci U S A. 1991;88:8101-8105.
17. Dichek D, Nerville RF, Zwiebel JA, Freeman SM, Leon MB, Anderson WF. Seeding of intravascular stents with genetically engineered endothelial cells. Circulation. 1989;80:1347-1353.
18. Lemarchand P, Jones M, Yamada I, Crystal RG. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res. 1993;72:1132-1138.
19. Morishita R, Gibbons GH, Kaneda Y, Ogihara T, Dzau VJ. Novel in vitro gene transfer method for study of local modulators in vascular smooth muscle cells. Hypertension. 1993;21:894-899.
20. Ooboshi H, Welsh MJ, Rios CD, Davidson BL, Heistad DD. Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue. Circ Res. 1995;77:7-13.
21. Katusic ZS, Milde JH, Cosentino F, Mitrovic BS. Subarachnoid hemorrhage and endothelial L-arginine pathway in small brain stem arteries in dogs. Stroke. 1993;24:392-399.
22. Kim P, Sundt TMJ, Vanhoutte PM. Alterations in endothelium-dependent responsiveness of the canine basilar artery after sub-arachnoid hemorrhage. J Neurosurg. 1988;69:239-246.
23. Varsos VG, Liszczak TM, Han DH, Kistler JP, Vielma J, Black PM, Heros RC, Zervas NT. Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a 'two-hemorrhage' canine model. J Neurosurg. 1983;58:11-17.
24. Zabner J, Couture LA, Smith AE, Welsh MJ. Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: efficacy of adenoviral-mediated gene transfer in vitro. Hum Gene Ther. 1994;5:585-593.
25. Hatake K, Wakabayashi I, Kakishita E, Hishida S. Impairment of endothelium-dependent relaxation in human basilar artery after subarachnoid hemorrhage. Stroke. 1992;23:1111-1117.
26. Sobey CG, Heistad DD, Faraci FM. Effect of subarachnoid hemorrhage on dilatation of rat basilar artery in vivo. Am J Physiol. 1996;40:H126-H132.
27. Simons M, Edelman ER, DeKeyser J, Langer R, Rosenberg RD. Antisense c-myb oligonucleotides inhibit arterial smooth muscle cell accumulation in vivo. Nature. 1992;359:67-70.
28. Edelman ER, Nugent MA, Karnovsky MJ. Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition. Proc Natl Acad Sci U S A. 1993;90: 1513-1517.
29. Villa AE, Guzman LA, Chen W, Golomb G, Levy RJ, Topol EJ. Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. J Clin Invest. 1994; 93:1243-1249.
30. Lee SW, Trapnell BC, Rade JJ, Virmani R, Dichek DA. In vitro adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ Res. 1993;73:797-807.
31. Schulick AH, Dong G, Newman KD, Virmani R, Dichek DA. Endothelium-specific in vivo gene transfer. Circ Res. 1995;77:475-485.
32. Rome JJ, Shayani V, Flugelman MY, Newman KD, Farb A, Virmani R, Dichek D. Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall: modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Arterioscler Thromb. 1994;14:148-161.
33. Ono T, Fujino Y, Tsuchiya T, Tsuda M. Plasmid DNAs directly injected into mouse brain with lipofectin can be incorporated and expressed by brain cells. Neurosci Lett. 1990;117:259-263.
34. Davidson BL, Doran SE, Shewach DS, Latta JM, Hartman JW, Roessler BJ. Expression of Escherichia coli β-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer. Exp Neurol. 1994;125:258-267.
35. Badie B, Hunt K, Economou JS, Black KL. Stereotactic delivery of a recombinant adenovirus into a C6 glioma cell line in a rat brain tumor model. Neurosurgery. 1994;35:910-916.
36. Kojima H, Inuzuka S, Miwa T, Furukawa S, Hayashi K, Kanegae Y, Saito I, Ohishi N, Takamori M, Yagi K. Construction and characterization of adenoviral vector expressing biologically active brain-derived neurotrophic factor. Biochem Biophys Res Commun. 1995;212:712-717.